JPS58220695A - トリメトプリム耐性の出現を目安とした転写翻訳活性を有するｄｎａ断片の検出方法 - Google Patents
トリメトプリム耐性の出現を目安とした転写翻訳活性を有するｄｎａ断片の検出方法Info
- Publication number
- JPS58220695A JPS58220695A JP57102553A JP10255382A JPS58220695A JP S58220695 A JPS58220695 A JP S58220695A JP 57102553 A JP57102553 A JP 57102553A JP 10255382 A JP10255382 A JP 10255382A JP S58220695 A JPS58220695 A JP S58220695A
- Authority
- JP
- Japan
- Prior art keywords
- dna
- transcription
- trimethoprim
- resistance
- plasmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000694 effects Effects 0.000 title claims abstract description 33
- 238000013519 translation Methods 0.000 title claims abstract description 29
- 229960001082 trimethoprim Drugs 0.000 title abstract description 34
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 title abstract description 34
- 238000013518 transcription Methods 0.000 title abstract description 17
- 230000035897 transcription Effects 0.000 title abstract description 17
- 238000001514 detection method Methods 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 39
- 239000013612 plasmid Substances 0.000 claims abstract description 23
- 241000894006 Bacteria Species 0.000 claims abstract description 13
- 239000013600 plasmid vector Substances 0.000 claims abstract description 13
- 239000003550 marker Substances 0.000 claims abstract description 4
- 230000002068 genetic effect Effects 0.000 claims abstract 3
- 230000002103 transcriptional effect Effects 0.000 claims description 23
- 239000012634 fragment Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 12
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 abstract description 3
- 239000013598 vector Substances 0.000 abstract description 2
- 230000002950 deficient Effects 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 description 37
- 230000014616 translation Effects 0.000 description 22
- 108091008146 restriction endonucleases Proteins 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 12
- 229960000723 ampicillin Drugs 0.000 description 9
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 108060002716 Exonuclease Proteins 0.000 description 5
- 239000004098 Tetracycline Substances 0.000 description 5
- 102000013165 exonuclease Human genes 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229960002180 tetracycline Drugs 0.000 description 5
- 229930101283 tetracycline Natural products 0.000 description 5
- 235000019364 tetracycline Nutrition 0.000 description 5
- 150000003522 tetracyclines Chemical class 0.000 description 5
- 108010022394 Threonine synthase Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 102000004419 dihydrofolate reductase Human genes 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000006916 nutrient agar Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 241000841159 Anaka Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229960001931 ampicillin sodium Drugs 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical group CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000613620 Homo sapiens Protein mono-ADP-ribosyltransferase PARP15 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102100040846 Protein mono-ADP-ribosyltransferase PARP15 Human genes 0.000 description 1
- 102000005157 Somatostatin Human genes 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- 239000005460 tetrahydrofolate Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57102553A JPS58220695A (ja) | 1982-06-15 | 1982-06-15 | トリメトプリム耐性の出現を目安とした転写翻訳活性を有するｄｎａ断片の検出方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57102553A JPS58220695A (ja) | 1982-06-15 | 1982-06-15 | トリメトプリム耐性の出現を目安とした転写翻訳活性を有するｄｎａ断片の検出方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58220695A true JPS58220695A (ja) | 1983-12-22 |
| JPS6132960B2 JPS6132960B2 (enrdf_load_stackoverflow) | 1986-07-30 |
Family
ID=14330429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57102553A Granted JPS58220695A (ja) | 1982-06-15 | 1982-06-15 | トリメトプリム耐性の出現を目安とした転写翻訳活性を有するｄｎａ断片の検出方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58220695A (enrdf_load_stackoverflow) |
-
1982
- 1982-06-15 JP JP57102553A patent/JPS58220695A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6132960B2 (enrdf_load_stackoverflow) | 1986-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2766621B2 (ja) | 組み換えｇ−ｃｓｆ | |
| Chen et al. | Phosphodiester bond cleavage outside mitochondria is required for the completion of protein import into the mitochondrial matrix | |
| FR2518572A1 (fr) | Plasmide d'expression permettant l'insertion appropriee d'adn heterologue | |
| CN100513548C (zh) | 将AcmA型蛋白质锚融合体与微生物细胞壁材料进行结合的改良方法 | |
| JPH09500538A (ja) | ナイセリア・メニンギチジス外膜グループｂポーリンタンパク質の高レベル発現、精製および再生 | |
| Sen et al. | Trimerization of an in vitro synthesized OmpF porin of Escherichia coli outer membrane | |
| JPS58220695A (ja) | トリメトプリム耐性の出現を目安とした転写翻訳活性を有するｄｎａ断片の検出方法 | |
| Nakamura et al. | L-Asparaginase from E. coli Part I. Crystallization and Properties | |
| Schulze et al. | The catalytic domain of the dihydrolipoyl transacetylase component of the pyruvate dehydrogenase complex From Azotobacter vinelandii and Escherichia coli: Expression, purification, properties and preliminary X‐ray analysis | |
| JPH04502260A (ja) | Ｎ―アセチルムラミダーゼ ｍ１ | |
| Lee et al. | The C terminus of the alpha subunit of RNA polymerase is not essential for transcriptional activation of sigma 54 holoenzyme | |
| RU2143492C1 (ru) | Рекомбинантная плазмида, кодирующая гибридный белок - предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка - предшественника инсулина человека (варианты), способ получения инсулина человека | |
| Kim et al. | Enhancement of mussel adhesive protein production in Escherichia coli by co‐expression of bacterial hemoglobin | |
| US20040175705A1 (en) | Systems for expression of heterologous proteins in m capsulatus | |
| CA2284111C (en) | Process for production of l-methionine .gamma.-lyase crystals | |
| Rizzo et al. | [2] Genetic approaches designed to minimize cytotoxicity of retroviral protease | |
| Moss et al. | [5] Activation of cholera toxin by ADP-ribosylation factors: 20-kDa guanine nucleotide-binding proteins | |
| RU2144082C1 (ru) | Рекомбинантная плазмида, кодирующая гибридный белок-предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка-предшественника инсулина человека (варианты) и способ получения инсулина человека | |
| Kwon et al. | Direct Cloning Method for Expression of Recombinant Proteins with an Inositol Hexakisphosphate Inducible Self-Cleaving Tag | |
| JPS591500A (ja) | ジヒドロ葉酸還元酵素遺伝子を利用したプロモ−タ検出用プラスミドベクタ−及びその製造方法 | |
| LT4034B (en) | Process for enzymatic decomposition of recombinant proteins by means of iga-protease, fused protein, recombinant dna, cell | |
| Aniskovitch et al. | Rickettsia prowazekii sigma factor σ73 can be overexpressed in Escherichia coli and promotes RNA polymerase binding and transcription | |
| EP0173937A2 (en) | Method of increasing the permeability of yeast cells | |
| CN117660419A (zh) | 水解活性提高的胶原酶及其应用 | |
| JP2002101887A (ja) | 組み換え型ｂ型肝炎ウイルス表面抗原の調製方法及び抗原 |